GlassScriptPhysician profile
Mallory B Anderson
NPI 1104166255
$7,008.16
in general payments reported to CMS, 2019-2025
39 companies · $1,888 in 2025
The $1,888 reported for 2025 was more than what 93% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $78.46 · 2022: $1,207 · 2023: $1,534 · 2024: $2,301 · 2025: $1,888.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,722.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,722.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,836.90 | 2021-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $538.02 | 2022-2025 | Xifaxan, Trulance |
| Takeda Pharmaceuticals U.S.A., INC. | $289.86 | 2022-2025 | Entyvio, Eohilia, Gattex |
| Ardelyx, INC. | $286.10 | 2022-2025 | Ibsrela |
| Pfizer INC. | $280.45 | 2022-2025 | |
| Ironwood Pharmaceuticals, INC | $230.75 | 2021-2024 | |
| Genzyme Corporation | $204.95 | 2023-2025 | |
| Madrigal Pharmaceuticals | $199.67 | 2024-2025 | Rezdiffra, Resmetirom |
| Regeneron Healthcare Solutions, INC. | $193.29 | 2024-2025 | Dupixent |
| Qol Medical, LLC | $188.83 | 2022-2025 | Sucraid, Sucraid |
| Janssen Biotech, INC. | $180.98 | 2023-2025 | Tremfya, Stelara, Simponi |
| Medtronic, INC. | $167.66 | 2025 | Interstim |
| Merck Sharp & Dohme LLC | $134.69 | 2022-2024 | Dificid |
| Aimmune Therapeutics, INC. | $131.54 | 2024-2025 | Vowst, Zenpep |
| Janssen Scientific Affairs, LLC | $124.52 | 2022 |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mallory Anderson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.